Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Overdose prescription errors sometimes cause serious life-threatening adverse drug events, while underdose errors lead to diminished therapeutic effects. Therefore, it is important to detect and prevent these errors. In the present study, we used the one-class support vector machine (OCSVM), one of the most common unsupervised machine learning algorithms for anomaly detection, to identify overdose and underdose prescriptions. We extracted prescription data from electronic health records in Kyushu University Hospital between January 1, 2014 and December 31, 2019. We constructed an OCSVM model for each of the 21 candidate drugs using three features: age, weight, and dose. Clinical overdose and underdose prescriptions, which were identified and rectified by pharmacists before administration, were collected. Synthetic overdose and underdose prescriptions were created using the maximum and minimum doses, defined by drug labels or the UpToDate database. We applied these prescription data to the OCSVM model and evaluated its detection performance. We also performed comparative analysis with other unsupervised outlier detection algorithms (local outlier factor, isolation forest, and robust covariance). Twenty-seven out of 31 clinical overdose and underdose prescriptions (87.1%) were detected as abnormal by the model. The constructed OCSVM models showed high performance for detecting synthetic overdose prescriptions (precision 0.986, recall 0.964, and F-measure 0.973) and synthetic underdose prescriptions (precision 0.980, recall 0.794, and F-measure 0.839). In comparative analysis, OCSVM showed the best performance. Our models detected the majority of clinical overdose and underdose prescriptions and demonstrated high performance in synthetic data analysis. OCSVM models, constructed using features such as age, weight, and dose, are useful for detecting overdose and underdose prescriptions.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8604308PMC
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0260315PLOS

Publication Analysis

Top Keywords

overdose underdose
28
underdose prescriptions
28
clinical overdose
12
underdose
9
unsupervised machine
8
machine learning
8
overdose
8
prescriptions
8
prescription data
8
constructed ocsvm
8

Similar Publications

This study compares the dosimetric performance of Base Dose Optimization (BDO) and Gradient-Based Optimization (GBO) for extended target volumes in Total Body Irradiation (TBI). The focus is on overlapping regions using the Rando Phantom. The study evaluates dose distribution, conformity, homogeneity, and sensitivity to positional deviations.

View Article and Find Full Text PDF

AI-Driven Tacrolimus Dosing in Transplant Care: Cohort Study.

JMIR AI

September 2025

Department of Medicine, University of California San Diego, 9500 Gilman Drive, La Jolla, CA, 92093-0881, United States, 1 4058504751.

Background: Tacrolimus forms the backbone of immunosuppressive therapy in solid organ transplantation, requiring precise dosing due to its narrow therapeutic range. Maintaining therapeutic tacrolimus levels in the postoperative period is challenging due to diverse patient characteristics, donor organ factors, drug interactions, and evolving perioperative physiology.

Objective: The aim of this study is to design a machine learning model to predict the next-day tacrolimus trough concentrations (C0) and guide dosing to prevent persistent under- or overdosing.

View Article and Find Full Text PDF

Anatomical changes in head-and-neck cancer (HNC) patients during intensity-modulated proton therapy (IMPT) can shift the Bragg Peak of proton beams, risking tumor underdosing and organ-at-risk (OAR) overdosing. As a result, treatment replanning is often required to maintain clinically acceptable treatment quality. However, current manual replanning processes are often resource intensive and time consuming.

View Article and Find Full Text PDF

Worst-Case Robustness Evaluation Methods for IMPT: A Critical Comparison.

Int J Part Ther

September 2025

Department of Radiation Oncology, Mayo Clinic, Jacksonville, Florida, USA.

Purpose: Robustness evaluation is routinely used in clinics to ensure the intended dose delivery for intensity-modulated proton therapy (IMPT). Various methods have been proposed, but there is no consensus on which method should be adopted in clinical practice. This study examined various methods within the widely used worst-case approach to provide insights into IMPT plan evaluation.

View Article and Find Full Text PDF

Background: Bispecific T-cell engagers (TCEs) are a promising modality for cancer treatment, and evaluation of dosing strategies, including utilization of body weight-based versus fixed dosing, is essential to ensure optimal therapeutic outcomes. Elranatamab is a bispecific TCE that targets B-cell maturation antigen (BCMA) on multiple myeloma cells and CD on T cells. Elranatamab is approved for relapsed or refractory multiple myeloma (RRMM).

View Article and Find Full Text PDF